Jared Holz, Mizuho, joins ‘Fast Money’ to talk the uptick in biotech and pharma M&A, what it is signaling, and how to play it.
If M&A continues at this pace you want to be long Biotech into next year, says Mizuho’s Jared Holz
Related posts
-
Bonds Extend Slide, Stocks Edge Up Toward Record Highs
Bloomberg TelevisionTue, October 6, 2026 4:43amURL:Embed:“Bloomberg: The Asia Trade” brings you everything you need to know... -
US Moves Bombers From UK Airbase as Threats Linger
Bloomberg TelevisionTue, October 6, 2026 4:43amURL:Embed:“Balance of Power” focuses on the intersection of politics and global... -
Trump promises $5,000 checks if Republicans win the midterms. Most voters doubt they’ll come
Yahoo FinanceTue, October 6, 2026 4:43amURL:Embed:President Trump is doubling down on his promise to send every...